MetaCap

Iovance Biotherapeutics Insider Trades

NASDAQ: IOVAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

14.62+1.31 (+9.84%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Iovance Biotherapeutics insider activity

Over the last 12 months, Iovance Biotherapeutics insiders reported 58 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Vogt Frederick G (Interim CEO & General Counsel) reporting a transaction in 15,626 shares on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IOVA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IOVA insider transactions

Iovance Biotherapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 8, 2026BILINSKY IGORChief Operating OfficerTax withholding3,976$34.59KForm 4
Sep 8, 2026BILINSKY IGORChief Operating OfficerOption exercise7,813—Form 4
Sep 8, 2026Puri Raj K.Chief Regulatory OfficerTax withholding4,478$38.96KForm 4
Sep 8, 2026Puri Raj K.Chief Regulatory OfficerOption exercise9,766—Form 4
Sep 8, 2026Vogt Frederick GInterim CEO & General CounselTax withholding6,638$57.75KForm 4
Sep 8, 2026Vogt Frederick GInterim CEO & General CounselOption exercise15,626—Form 4
Sep 1, 2026Puri Raj K.Chief Regulatory OfficerTax withholding2,508$20.77KForm 4
Sep 1, 2026Puri Raj K.Chief Regulatory OfficerOption exercise5,470—Form 4
Sep 1, 2026Vogt Frederick GInterim CEO & General CounselTax withholding17,702$146.57KForm 4
Sep 1, 2026Vogt Frederick GInterim CEO & General CounselOption exercise41,669—Form 4
Sep 1, 2026BILINSKY IGORChief Operating OfficerTax withholding4,472$37.03KForm 4
Sep 1, 2026BILINSKY IGORChief Operating OfficerOption exercise8,789—Form 4
Aug 10, 2026Kirby Daniel GordonChief Commercial OfficerTax withholding2,436$15.59KForm 4
Aug 10, 2026Kirby Daniel GordonChief Commercial OfficerOption exercise10,001—Form 4
Aug 6, 2026Roche Corleen M.Chief Financial OfficerTax withholding21,238$131.89KForm 4
Aug 6, 2026Roche Corleen M.Chief Financial OfficerOption exercise49,995—Form 4
Jun 5, 2026Puri Raj K.Chief Regulatory OfficerTax withholding3,843$16.26KForm 4
Jun 5, 2026Puri Raj K.Chief Regulatory OfficerOption exercise9,766—Form 4
Jun 5, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding3,976$16.82KForm 4
Jun 5, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise7,813—Form 4
Jun 5, 2026Vogt Frederick GInterim CEO & General CounselTax withholding6,638$28.08KForm 4
Jun 5, 2026Vogt Frederick GInterim CEO & General CounselOption exercise15,625—Form 4
Jun 5, 2026BILINSKY IGORChief Operating OfficerTax withholding3,976$16.82KForm 4
Jun 5, 2026BILINSKY IGORChief Operating OfficerOption exercise7,813—Form 4
Jun 1, 2026BILINSKY IGORChief Operating OfficerTax withholding4,473$17.71KForm 4
Jun 1, 2026BILINSKY IGORChief Operating OfficerOption exercise8,790—Form 4
Jun 1, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding4,473$17.71KForm 4
Jun 1, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise8,790—Form 4
Jun 1, 2026Puri Raj K.Chief Regulatory OfficerTax withholding2,508$9.93KForm 4
Jun 1, 2026Puri Raj K.Chief Regulatory OfficerOption exercise5,469—Form 4
Jun 1, 2026Vogt Frederick GInterim CEO & General CounselTax withholding17,701$70.10KForm 4
Jun 1, 2026Vogt Frederick GInterim CEO & General CounselOption exercise41,668—Form 4
May 11, 2026Kirby Daniel GordonChief Commercial OfficerTax withholding2,435$9.01KForm 4
May 11, 2026Kirby Daniel GordonChief Commercial OfficerOption exercise10,000—Form 4
Mar 5, 2026Puri Raj K.Chief Regulatory OfficerTax withholding18,360$84.09KForm 4
Mar 5, 2026Puri Raj K.Chief Regulatory OfficerOption exercise39,059—Form 4
Mar 5, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding16,520$75.66KForm 4
Mar 5, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise31,246—Form 4
Mar 5, 2026BILINSKY IGORChief Operating OfficerTax withholding16,628$76.16KForm 4
Mar 5, 2026BILINSKY IGORChief Operating OfficerOption exercise31,246—Form 4
Mar 5, 2026Vogt Frederick GInterim CEO & General CounselTax withholding26,755$122.54KForm 4
Mar 5, 2026Vogt Frederick GInterim CEO & General CounselOption exercise62,493—Form 4
Mar 2, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding7,122$26.99KForm 4
Mar 2, 2026GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise12,697—Form 4
Mar 2, 2026Puri Raj K.Chief Regulatory OfficerTax withholding2,798$10.60KForm 4
Mar 2, 2026Puri Raj K.Chief Regulatory OfficerOption exercise5,470—Form 4
Mar 2, 2026BILINSKY IGORChief Operating OfficerTax withholding6,903$26.16KForm 4
Mar 2, 2026BILINSKY IGORChief Operating OfficerOption exercise12,307—Form 4
Mar 2, 2026Vogt Frederick GInterim CEO & General CounselTax withholding22,809$86.45KForm 4
Mar 2, 2026Vogt Frederick GInterim CEO & General CounselOption exercise52,087—Form 4
Feb 24, 2026Kirby Daniel GordonChief Commercial OfficerTax withholding34,165$129.14KForm 4
Feb 24, 2026Kirby Daniel GordonChief Commercial OfficerOption exercise120,000—Form 4
Feb 10, 2026Kirby Daniel GordonChief Commercial OfficerTax withholding16,450$42.77KForm 4
Feb 10, 2026Kirby Daniel GordonChief Commercial OfficerOption exercise39,996—Form 4
Dec 2, 2025GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding1,984$4.25KForm 4
Dec 2, 2025GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise3,906—Form 4
Dec 1, 2025GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerTax withholding4,464$9.95KForm 4
Dec 1, 2025GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOption exercise8,789—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related